STAAR Surgical Company (STAA)
NASDAQ
22.32
+0.44 (+2.01%)
Closed
Oct 20, 2026
Day's Range
21.8522.57
52 wk Range
15.5935.87
Financial Statements - STAA - STAAR Surgical Company
Revenue
239.44M▼ 23.7%
Net Income
-80.44M▼ 298.1%Net Margin -33.6%
EBITDA
5.94M▲ 390.8%
Free Cash Flow
-40.05M▼ 422.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 239.44M | 313.90M | 322.41M | 284.39M | 230.47M | 163.46M |
| Cost of Goods | 57.02M | 74.31M | 69.76M | 61M | 51.83M | 45.09M |
| Gross Profit | 182.42M | 239.58M | 252.65M | 223.38M | 178.63M | 118.36M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -45.94M | -12.61M | 28.09M | 43.80M | 33.33M | 6.76M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -40.91M | -2.35M | -1.38M | -698K | -1.99M | 1.26M |
| Pre Tax Income | -82.26M | -9.05M | 33.69M | 45.55M | 31.30M | 8.26M |
| Income Tax | -1.81M | 11.15M | 12.34M | 5.88M | 3.79M | 2.35M |
| Net Income | -80.44M | -20.20M | 21.34M | 39.66M | 27.51M | 5.91M |
| EPS Basic | -1.62 | -0.41 | 0.44 | 0.81 | 0.52 | 0.13 |
| EPS Diluted | -1.62 | -0.41 | 0.43 | 0.79 | 0.5 | 0.12 |
| Basic Shares Outstanding | 49.56M | 49.12M | 48.52M | 47.98M | 47.21M | 45.60M |
| Diluted Shares Outstanding | 49.56M | 49.12M | 48.52M | 47.98M | 47.21M | 45.60M |
| Ebit | -45.94M | -12.61M | 28.09M | 43.80M | 33.33M | 6.76M |
| Ebitda | 5.94M | -2.04M | 35.13M | 50.01M | 39.94M | 9M |
| Net Income Continuous Operations | -80.44M | -20.20M | 21.34M | 39.66M | 27.51M | 5.91M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
